SOPRA_STERIA_REGISTRATION_DOCUMENT_2017
2017 CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements
7.1.2. Other loans and receivables
31/12/2017
31/12/2016
(in millions of euros)
Loans
0.1
0.1 1.1 1.8 5.9
CIR and CICE tax credit receivables* Other non-current receivables
-
2.2 8.2
Deposits and other non-current financial assets
Provisions for loans, deposits and other non-current financial assets
-0.1
-0.4 8.5
TOTAL
10.4
* CIR : R&D Tax credit ; CICE : competitivences and jobs tax credit.
R&D tax credit receivables classified as Other loans and receivables are those which will be used or redeemed after more than one year. During the 2016 financial year, they were reclassified to Other current assets . Deposits and other non-current financial assets mainly include guarantees given for leased premises and receivables relating to equity investments.
Other non-current receivables mainly consist of advances paid by the NHS SBS entity to new customers of its platform to facilitate their migration. These deposits and other receivables are held at their nominal value, given that the effect of discounting is not material.
7.2. Trade accounts receivable
31/12/2017
31/12/2016
(in millions of euros)
Trade accounts receivable – gross value
666.1 483.1 -11.4
674.1 468.4
Accrued income
Impairment of trade accounts receivable
-9.8
TOTAL
1,137.8
1,132.7
comparing Net trade accounts receivable with the revenue generated in the final quarter of the reporting period. Net trade accounts receivable is obtained by eliminating VAT from the Trade accounts receivable balance and subtracting the deferred income balance appearing under liabilities. Accrued income is comprised essentially of work performed in respect of fixed-price projects recognised using the percentage-of-completion method (see Note 4.1.a) and also includes the transition costs. These consist of costs relating to services in progress initiated during the start-up phase of certain major contracts, and correspond to activities that will generate future economic benefits.
In December 2017, the Group completed the sale of trade accounts receivable in France for a total value of €56.8 million, compared with €25.0 million in December 2016. In 2017, the sale of receivables were made with recourse in the amount of €19.8 million and without recourse in the amount of €37.0 million. Only receivables sold without recourse were removed from the balance sheet. In 2016, as the sale was made with recourse, the receivables were not removed from the balance sheet. Net trade accounts receivable , expressed in terms of months of revenue, corresponded to about 2.0 months of revenue at 31 December 2017, versus 2.2 months at 31 December 2016. This ratio is calculated by
7.2.1. Aged trade accounts receivable
Of which: past due, with the following breakdown
Of which: not past due at the balance sheet date
Between 30 and 90 days
Between 90 and 120 days
Carrying amount
Less than 30 days
More than 120 days
(in millions of euros)
Trade accounts receivable
666.1
427.9
140.5
40.1
12.4
45.2
7.2.2. Statement of changes in provisions for trade accounts receivable
31/12/2017
31/12/2016
(in millions of euros)
Provisions for trade accounts receivable at 1 January
9.8 0.1 2.9 -1.4
9.2 0.6 -0.8
Changes in scope
Additions net of reversals
Reclassification
1.0
Translation adjustments
-
-0.2 9.8
PROVISIONS FOR TRADE ACCOUNTS RECEIVABLE AT PERIOD-END
11.4
159
SOPRA STERIA REGISTRATION DOCUMENT 2017
Made with FlippingBook - Online catalogs